The 15-minute chart of Madrigal has triggered a Golden Cross on the KDJ indicator and a Bullish Marubozu at 13:00 on September 10, 2026. This suggests a shift in momentum towards the upside and a potential increase in the stock price. With buyers dominating the market, it is likely that the bullish momentum will continue.On September 10, 2026, the 15-minute chart of Madrigal Pharmaceuticals, Inc. (MDGL) displayed a Golden Cross on the KDJ indicator and a Bullish Marubozu at 13:00, signaling a potential shift in momentum toward the upside. These technical indicators suggest that buyers are currently in control, with the stock poised for a <a href="https://www.google.com/goto?url=CAEShwEB6zswFVNYvqYOeNUVc22WHuZaGo9EO-gpST1cF92kS-Q40jFiynKpGWiGWpHVsG86sKJ0XfJJb1OGjFi1lCpc8tmCKYegsUy91Qs4UMooHJ51P7XoKJGEFGXOpNpexBpR1zDQqhvy6uDfe6r3ZVJV3dnqf0gaDH0KQckaMH1VZbmV8HSLTPI">possible price increase</a>.This development aligns with recent technical and fundamental trends. MDGL’s 50-day simple moving average recently crossed above its 200-day moving average, forming a Golden Cross, <a href="https://www.google.com/goto?url=CAEShwEB6zswFVNYvqYOeNUVc22WHuZaGo9EO-gpST1cF92kS-Q40jFiynKpGWiGWpHVsG86sKJ0XfJJb1OGjFi1lCpc8tmCKYegsUy91Qs4UMooHJ51P7XoKJGEFGXOpNpexBpR1zDQqhvy6uDfe6r3ZVJV3dnqf0gaDH0KQckaMH1VZbmV8HSLTPI">historically associated with bullish momentum</a>. Over the past four weeks, the stock has gained 62.2%, and it is currently rated a #2 (Buy) on the Zacks Rank. Additionally, earnings estimates have improved, with <a href="https://www.google.com/goto?url=CAEShwEB6zswFVNYvqYOeNUVc22WHuZaGo9EO-gpST1cF92kS-Q40jFiynKpGWiGWpHVsG86sKJ0XfJJb1OGjFi1lCpc8tmCKYegsUy91Qs4UMooHJ51P7XoKJGEFGXOpNpexBpR1zDQqhvy6uDfe6r3ZVJV3dnqf0gaDH0KQckaMH1VZbmV8HSLTPI">nine upward revisions</a> in the past 60 days.From a fundamental perspective, MDGL reported total revenue of $958.40 million for the past fiscal year, with a 432.05% increase compared to the prior year. However, the company continues to report net losses, with a <a href="https://www.google.com/goto?url=CAESXwHrOzAV2e6yO_Vd2q63FMu38JvJh9UuCu0HFnoy1kFeYS8U4rQpXbHY8IyQk7_XjAcUOyRPjdjeyazkaFkXJET-n0go5gWBN61kTlaNNhlUgy4mA1GUPrh_8AzipmHk">net income of -$288.28 million</a> for the same period. Despite this, the recent technical signals and improving earnings expectations may indicate a strengthening outlook for the stock. Investors are advised to monitor MDGL closely for further signs of momentum.

Madrigal's 15-minute chart shows KDJ Golden Cross and bullish Marubozu signals.

The 15-minute chart of Madrigal's stock has recently triggered a MACD Death Cross, KDJ Death Cross, and a Bearish Marubozu on September 10, 2026 at 09:45. This indicates that the stock price has the potential to continue its downward trend, as the momentum of the stock price is shifting towards the downside and may further decrease. The market is currently controlled by sellers, and it is likely that bearish momentum will continue.On September 10, 2026, at 09:45, the 15-minute chart of Madrigal Pharmaceuticals, Inc. (MDGL) triggered a MACD Death Cross, KDJ Death Cross, and a Bearish Marubozu candlestick pattern, signaling a potential continuation of the downward trend in the stock price. These technical indicators suggest that the momentum has shifted to the bearish side, with <a href="https://www.google.com/goto?url=CAESYgHrOzAVDM_k7vTjc2egMTmkUrHl0WCKzSWHuInKKUinCVJnvdrA732f2djNZ_4MMotlFnmtGE3xy6iZfinmolXpN4wqzt4Aitrs8ZK8_8kLcS9lcMkBtP1aNmOIviDpA9CL">sellers currently dominating the market</a>.The MACD Death Cross occurs when the MACD line crosses below the signal line, often viewed as a bearish reversal pattern. Similarly, the KDJ Death Cross, where the K line crosses below the D line, reinforces the bearish sentiment. The Bearish Marubozu candlestick, characterized by a long lower shadow and no upper shadow, further indicates <a href="https://www.google.com/goto?url=CAESYgHrOzAVDM_k7vTjc2egMTmkUrHl0WCKzSWHuInKKUinCVJnvdrA732f2djNZ_4MMotlFnmtGE3xy6iZfinmolXpN4wqzt4Aitrs8ZK8_8kLcS9lcMkBtP1aNmOIviDpA9CL">strong selling pressure</a> and a lack of buying interest.MDGL closed at $529.075 on the previous trading day, reflecting a -3.22% decline from its prior close. Over the past 10 trading days, the stock has fallen in 5 of those sessions, with a cumulative decline of 6.74%. The trading volume on the last session was 281.25K shares, with a <a href="https://www.google.com/goto?url=CAESYgHrOzAVDM_k7vTjc2egMTmkUrHl0WCKzSWHuInKKUinCVJnvdrA732f2djNZ_4MMotlFnmtGE3xy6iZfinmolXpN4wqzt4Aitrs8ZK8_8kLcS9lcMkBtP1aNmOIviDpA9CL">notable drop in volume</a> on the previous day.While the stock has generated five bullish technical signals, including positive readings on the Awesome Oscillator and Moving Average Convergence Divergence (MACD), it also has <a href="https://www.google.com/goto?url=CAESYgHrOzAVDM_k7vTjc2egMTmkUrHl0WCKzSWHuInKKUinCVJnvdrA732f2djNZ_4MMotlFnmtGE3xy6iZfinmolXpN4wqzt4Aitrs8ZK8_8kLcS9lcMkBtP1aNmOIviDpA9CL">one bearish signal from</a> the Williams %R indicator. The overall technical rating for MDGL remains a "Strong Buy," but the <a href="https://www.google.com/goto?url=CAESYgHrOzAVDM_k7vTjc2egMTmkUrHl0WCKzSWHuInKKUinCVJnvdrA732f2djNZ_4MMotlFnmtGE3xy6iZfinmolXpN4wqzt4Aitrs8ZK8_8kLcS9lcMkBtP1aNmOIviDpA9CL">recent bearish candlestick patterns</a> suggest caution for short-term traders.Investors should monitor key support levels at $505.84 and $488.80, as a breakdown below these levels could trigger further sell signals. The market remains volatile, and traders are advised to remain vigilant as the bearish momentum appears to be gaining strength.

Madrigal's 15min Chart Triggers MACD Death Cross, KDJ Death Cross, Bearish Marubozu

Madrigal's 15-minute chart has triggered a MACD Death Cross and a KDJ Death Cross, which occurred on September 9, 2026 at 10:15. This suggests that the stock price may continue to decline and that momentum is shifting towards the downside, potentially leading to further decreases.On September 9, 2026 at 10:15, Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) experienced a technical signal indicating potential downward momentum in its stock price. The 15-minute chart for MDGL triggered both a MACD Death Cross and a KDJ Death Cross, suggesting <a href="https://www.google.com/goto?url=CAES2wEB6zswFZ-ROQxU_Wn16bMe0YNsDvt4rf5Y3BShY3zBpmnpB45m4HVPTGWPM3c2jJ255n_Qed16wDG7euX7xQ80FaAbh4kY3j8lQdaDPsd2tLxncIUyrCgI68dEeoxgZbKm5JvqmyBc2v_NCVz9fxnmworD5VQtlNaFKdhDRpvLnNYiJOJW7jQXrGC4hCit9hw6ln_BuP5s3x3P6BXW0aDFrbLalc0o_ws8krP08a0WgGOoo1VDq69n95ef-U-6OE64L_Fq_TDSpD3BuFZHLD9p7GP8mOk404c06mM">a possible continuation of the stock's decline</a>. These indicators are commonly used by traders to assess short-term market trends and momentum. While technical analysis does not predict future performance with certainty, such signals often prompt investors to reassess their positions or monitor the stock more closely for further developments. Investors are advised to consider these signals in conjunction with broader market conditions and fundamental analysis when making investment decisions. As with all technical indicators, the significance of these events should be evaluated within the context of a comprehensive trading strategy.

Madrigal's 15min chart shows MACD Death Cross, KDJ Death Cross

The 15-minute chart for Madrigal has triggered a KDJ Death Cross and a Bearish Marubozu at 09/08/2026 15:30. This indicates a shift in the momentum of the stock price towards the downside, with a potential for further decreases in value. Sellers are currently controlling the market, and it is likely that the bearish momentum will continue.On September 8, 2026, at 15:30, the 15-minute chart for Madrigal Pharmaceuticals, Inc. (MDGL) displayed a KDJ Death Cross and a Bearish Marubozu pattern, signaling a potential shift in momentum toward the downside. These technical indicators suggest that sellers are currently in control, with the stock price likely to experience further declines in the near term. The Bearish Marubozu, characterized by a long bearish candle with little to no upper shadow, reinforces <a href="https://www.google.com/goto?url=CAESdgHrOzAV5sFDUQNaFZ_mBPB6AseVyOdI7wLeXvuRcQ0B6ed32Msn6MFVBrFUSz9jTizXWj9iQoKUptvt6PW847hbwVPS0EHchxZKxcb7_OgchDnMf5pdjz0uxx6lY0_Eb8Fyn5HvrRKD9rHcEpjzON5dauQgCaI">the strength of the selling pressure</a> during the session.Madrigal Pharmaceuticals has shown strong performance over the past five years, with <a href="https://www.google.com/goto?url=CAESXQHrOzAVqrxZ7kf-DVe7XQM7Eb8a3HAEGyGjAEC8x92GnkDmozWiP-bltlR5vJdZyLxbR4ezy5-MTcc5FBLVtrsDpVqoYpGpC9O-qvsJbD43m6eg-frj-iLosdutZQ">total return of 582.85%</a> compared to the S&amp;P 500’s 70.23% over the same period. However, recent technical signals indicate a potential reversal in the stock’s short-term trajectory. Investors are advised to monitor subsequent price action and volume for confirmation of the bearish trend. As always, technical analysis should be used in conjunction with fundamental research and broader market conditions to inform investment decisions.

Madrigal's 15min chart indicates KDJ Death Cross, bearish Marubozu signal.

As of September 2, 2023 at 13:45, Madrigal's 15-minute chart has triggered a KDJ Golden Cross and a Bullish Marubozu. This indicates a shift in the momentum of the stock price towards the upside, with potential for further growth. Currently, buyers are in control of the market, and it is likely that bullish momentum will continue.As of September 2, 2023, Madrigal Pharmaceuticals Inc. (MDGL) has shown signs of a potential upward shift in momentum. The 15-minute chart has triggered a KDJ Golden Cross and a Bullish Marubozu, suggesting <a href="https://www.barchart.com/stocks/quotes/MDGL/technical-analysis">a short-term bullish reversal</a> and increased buying pressure. These technical signals indicate that buyers are currently in control, with the potential for continued upward movement in the stock price.From a broader perspective, MDGL has demonstrated mixed performance across key technical indicators. Over the 20-day period, the stock has gained 17.01%, with a moving average of 500.29 and an <a href="https://www.barchart.com/stocks/quotes/MDGL/technical-analysis">average trading volume of 394,105 shares</a>. However, the year-to-date performance shows a decline of 10.95%, reflecting ongoing volatility. The 14-day stochastic reading stands at 54.03%, with %K at 60.48% and %D at 62.35%, indicating <a href="https://www.barchart.com/stocks/quotes/MDGL/technical-analysis">moderate bullish momentum</a>.While these signals suggest a potential continuation of the upward trend, investors should remain cautious and consider broader market conditions and fundamental factors before making investment decisions.

Madrigal's 15min chart triggers KDJ Golden Cross, bullish Marubozu formation.

Catalyst<ul> <li>Majority of analysts rate MDGL Buy or Strong Buy, showing broad institutional optimism.</li> <li>Net fund flow trends are positive, with large and extra-large investors showing inflows.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state, and the direction is not clear enough.</li> <li>The company shows negative factors in return on total assets and net profit margin metrics.</li></ul>

Key Factors

On September 11, 2026, Madrigal Pharmaceuticals (MDGL) President and CEO William John Sibold sold 5,221 shares for an estimated $2,831,801, leaving him with 202,907 shares.

MDGL News